Literature DB >> 12191515

Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones.

Christine Brostjan1, Teresa Bellón, Yuri Sobanov, Miguel López-Botet, Erhard Hofer.   

Abstract

Natural killer cells are known to express a variety of surface receptors involved in HLA class I monitoring. It is thus of interest to investigate the clonal distribution and relative expression levels of activating versus inhibitory NK receptors. We have developed a quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) assay designed to determine specific and absolute mRNA levels for NKG2-A/B, -C, -E, -F, -H and NKG2-D. When analyzing NK cell clones derived from a single donor we found differential expression of inhibitory (NKG2-A/B) versus triggering (NKG2-C and potentially -E, -F, -H) NK receptor chains. The generation of the splice variants NKG2-E and -H seemed to occur at a constant ratio. We further compared NKG2 transcript levels to surface receptor expression as monitored by flow cytometric analysis and to NK cell cytotoxicity as detected by reverse ADCC: a clear correlation was observed. Thus, the data obtained reveal a substantial variability in the NKG2 repertoire among NK cell subpopulations, which is likely to affect the sensitivity and reactivity towards the ligand HLA-E.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12191515     DOI: 10.1016/s0022-1759(02)00084-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

Review 1.  Structural insights into activation of antiviral NK cell responses.

Authors:  Kathryn A Finton; Roland K Strong
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

2.  Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.

Authors:  Susan L Heatley; Gabriella Pietra; Jie Lin; Jacqueline M L Widjaja; Christopher M Harpur; Sue Lester; Jamie Rossjohn; Jeff Szer; Anthony Schwarer; Kenneth Bradstock; Peter G Bardy; Maria Cristina Mingari; Lorenzo Moretta; Lucy C Sullivan; Andrew G Brooks
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

3.  Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.

Authors:  Lilach Kleinberg; Vivi Ann Flørenes; Martina Skrede; Hiep Phuc Dong; Søren Nielsen; Michael T McMaster; Jahn M Nesland; Ie-Ming Shih; Ben Davidson
Journal:  Virchows Arch       Date:  2006-03-16       Impact factor: 4.064

4.  Neutralizing type I IFN antibodies trigger an IFN-like response in endothelial cells.

Authors:  Herwig Peter Moll; Harald Freudenthaler; Anna Zommer; Elisabeth Buchberger; Christine Brostjan
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

5.  Ex vivo generated natural killer cells acquire typical natural killer receptors and display a cytotoxic gene expression profile similar to peripheral blood natural killer cells.

Authors:  Dorit Lehmann; Jan Spanholtz; Markus Osl; Marleen Tordoir; Karoline Lipnik; Martin Bilban; Bernhard Schlechta; Harry Dolstra; Erhard Hofer
Journal:  Stem Cells Dev       Date:  2012-07-17       Impact factor: 3.272

Review 6.  Dimorphism of HLA-E and its Disease Association.

Authors:  Leonid Kanevskiy; Sofya Erokhina; Polina Kobyzeva; Maria Streltsova; Alexander Sapozhnikov; Elena Kovalenko
Journal:  Int J Mol Sci       Date:  2019-11-04       Impact factor: 5.923

7.  Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors.

Authors:  Ilona Hromadnikova; Petra Pirkova; Lucie Sedlackova
Journal:  Mediators Inflamm       Date:  2013-02-17       Impact factor: 4.711

8.  Increased HLA-E expression in white matter lesions in multiple sclerosis.

Authors:  Pascal F Durrenberger; Louise V Webb; Malcolm J W Sim; Richard S Nicholas; Daniel M Altmann; Rosemary J Boyton
Journal:  Immunology       Date:  2012-12       Impact factor: 7.397

9.  CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.

Authors:  Emma J Petrie; Craig S Clements; Jie Lin; Lucy C Sullivan; Darryl Johnson; Trevor Huyton; Annie Heroux; Hilary L Hoare; Travis Beddoe; Hugh H Reid; Matthew C J Wilce; Andrew G Brooks; Jamie Rossjohn
Journal:  J Exp Med       Date:  2008-03-10       Impact factor: 14.307

10.  NKG2H-Expressing T Cells Negatively Regulate Immune Responses.

Authors:  Daniela Dukovska; Daniel Fernández-Soto; Mar Valés-Gómez; Hugh T Reyburn
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.